Zacks Investment Research on MSN
Strategic Deals Drive TEM Growth Amid Competition: Buy, Hold or Sell?
Tempus AI, Inc. TEM continues to strengthen its position in precision medicine through strategic acquisitions. In a move to expand its digital pathology capabilities, the company announced the $81.25 ...
Stocks like Bank of India, Metropolis Healthcare, Dilip Buildcon, LTIMindtree, Brigade Enterprises, Zydus Lifesciences, Coal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback